ArticleJournal of diabetes investigation2026
Association between the cholesterol-high-density lipoprotein-glucose index and the incidence of new-onset diabetes in patients with chronic gastrointestinal diseases: A prospective cohort study.
Article in Journal of diabetes investigation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimsThis study aimed to investigate the association between the cholesterol-high-density lipoprotein-glucose (CHG) index and the incidence of diabetes in patients with chronic gastrointestinal diseases (CGID).
methodsThis study utilized data from the China Health and Retirement Longitudinal Study (CHARLS) for the period 2011-2020. The association between the CHG index and new-onset diabetes was assessed using Cox proportional hazards models. Restrictive cubic spline (RCS) analysis was used to examine the dose-response relationship, and time-window analysis assessed the time-dependence of predictive performance. The independent contributions of individual components of the CHG index were investigated using a two-axis decomposition (metabolic burden axis and lipid protection axis).
resultsThis study enrolled 1,870 CGID patients who were free of diabetes at baseline. During the follow-up period, 289 participants (15.5%) developed new-onset diabetes. CHG index was associated with the risk of new-onset diabetes (HR per 1-SD increase = 1.44, 95% CI: 1.28-1.61). RCS analysis showed no nonlinear relationship (P-nonlinear = 0.773). Time-window analysis showed that the predictive performance of the CHG index increased over time (HR for 0-5 years = 1.33 vs HR for 5-9 years = 1.62, P-interaction <0.001). Two-axis decomposition analysis revealed that the 'high metabolic burden-low lipid protection' group had the highest risk of diabetes (HR = 2.00).
conclusionsThe CHG index is an independent risk factor for new-onset diabetes in CGID patients, showing a linear dose-response relationship and time-dependent predictive performance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.